Mihaela Skobe, PhD
Dr. Skobe obtained her bachelor’s degree in Molecular Biology at the University of Zagreb (Croatia), and completed her PhD in Cell Biology at the German Cancer Research Center in Heidelberg and at the University of Darmstadt (Germany). Her PhD thesis focused on the role of the microenvironment in the early stages of skin carcinogenesis, and demonstrated the fundamental role of activated stromal cells in inducing tumor growth and invasiveness. Her early studies of tumor angiogenesis were among the first to show the effectiveness of VEGFR-2 inhibition in preclinical models of cancer. Following her postdoctoral work at the Massachusetts General Hospital/Harvard Medical School, she joined the Department of Oncological Sciences at the Icahn School of Medicine at Mount Sinai in New York, where she began and built a research program focused on cancer metastasis and lymphatic vasculature. Dr. Skobe has pioneered the field of tumor lymphangiogenesis, and her discoveries have drawn major attention to the importance of lymphatic vasculature in cancer. She serves on numerous national and international advisory committees and review boards, has been the recipient of several awards, and was honored by the Lymphatic Research Foundation for her exceptional contributions to the field of lymphatic research.
Dr. Skobe is on Twitter at @LabSkobe
Cancer, Chemokines, Growth Factors and Receptors, Lymphangiogenesis, Metastasis
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Immunology [IMM]